Clinical trial Recruiting at 1 site Interventional Ages 18 and up

VR circadian reset to change REM sleep and reduce binge eating

Official title: Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control Through Improved Network Connectivity in Brain in Patients With Binge Eating Disorder

Run by Icahn School of Medicine at Mount Sinai · NCT06858774 · Data updated 2026-11-12

This trial uses a VR-based circadian reset program to try to reduce binge-eating episodes in adults with binge-eating disorder.

More Binge-Eating Disorder trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 13, 2025
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedApril 20, 2026
Trial IDNCT06858774 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with a confirmed diagnosis of binge-eating disorder who are English-speaking, have at least some sleep disturbance, and have no medical/vestibular conditions that make VR unsafe are ideal candidates.

Probably not a fit

People with good baseline sleep (PSQI <5), pregnancy, active suicidal ideation, or medical conditions that increase VR risk (seizure risk, unstable cardiac disease, significant vision or inner-ear problems) would be unlikely to benefit or be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Forty adults with diagnosed binge-eating disorder will be randomized to use a VR headset twice daily for one month with either circadian reset technology (CRT) software or a control software. Each VR session is 5 minutes on waking and 5 minutes before sleep, with baseline, weekly, daily EMA, and a 1-month follow-up including repeat measures and fMRI. Primary outcome is change in binge eating frequency; secondary outcomes include sleep quality, appetite regulation, food craving/impulsivity, mood, and fMRI functional connectivity. All recruitment, device setup, and key visits (including the fMRI) are conducted through the Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai.

Why it matters

Potential benefit: If successful, this non-drug approach could reduce binge-eating episodes by improving sleep and appetitive control.

How similar studies have gone: Light- and circadian-based interventions have shown promise for sleep and mood, but using VR-delivered circadian reset specifically to reduce binge eating is largely novel and not well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 18+
* Diagnosed with Binge Eating Disorder using EDA-5
* English-speaking

Exclusion Criteria:

* Pregnancy
* Acute suicide risk/active suicidal ideation
* PSQI score \<5 indicating good sleep quality
* A condition that may create a risk while using the VR headset including risk of falls, seizures, a heart condition, migraines, an eye or vision condition, or an inner ear condition.

Where it's running

  • Department of Psychiatry, Eating and Weight Disorders Program
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.